[3-(hydroxymethyl)pyrrolidin-1-yl]-[4-methyl-3-[6-(trifluoromethyl)-1H-isoindol-4-yl]phenyl]methanone
C22H21F3N2O2 — CID 148634789
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(hydroxymethyl)pyrrolidin-1-yl]-[4-methyl-3-[6-(trifluoromethyl)-1H-isoindol-4-yl]phenyl]methanone
[3-(hydroxymethyl)pyrrolidin-1-yl]-[4-methyl-3-[6-(trifluoromethyl)-1H-isoindol-4-yl]phenyl]methanone (PubChem CID 148634789) has the molecular formula C22H21F3N2O2 and a molecular weight of 402.42 g/mol. Its IUPAC name is [3-(hydroxymethyl)pyrrolidin-1-yl]-[4-methyl-3-[6-(trifluoromethyl)-1H-isoindol-4-yl]phenyl]methanone.
Molecular Properties
| Compound Name | [3-(hydroxymethyl)pyrrolidin-1-yl]-[4-methyl-3-[6-(trifluoromethyl)-1H-isoindol-4-yl]phenyl]methanone |
|---|---|
| PubChem CID | 148634789 |
| Molecular Formula | C22H21F3N2O2 |
| Molecular Weight | 402.42 g/mol |
| Exact Mass | 402.16 |
| IUPAC Name | [3-(hydroxymethyl)pyrrolidin-1-yl]-[4-methyl-3-[6-(trifluoromethyl)-1H-isoindol-4-yl]phenyl]methanone |
| SMILES | Cc1ccc(C(=O)N2CCC(CO)C2)cc1-c1cc(C(F)(F)F)cc2c1C=NC2 |
| InChI | InChI=1S/C22H21F3N2O2/c1-13-2-3-15(21(29)27-5-4-14(11-27)12-28)7-18(13)19-8-17(22(23,24)25)6-16-9-26-10-20(16)19/h2-3,6-8,10,14,28H,4-5,9,11-12H2,1H3 |
| InChIKey | NIVXJAIFVITAQZ-UHFFFAOYSA-N |
| XLogP | 4.07 |
| TPSA | 52.90 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.42 |
| LogP ≤ 5 | 4.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 148634789 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.